Sign Up Now to Download a Free Research Report on
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? Vivus
VIVUS shares surged 5.56 percent on more than three times the average daily volume Tuesday to close at $11.78 a share. The biotech company announced that it has received approval from the FDA to begin selling its weight loss drug Qsymia through certified retail pharmacies.
Going forward ... (see research report)
Subscribe to News Feeds